Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Vertex Pharmaceuticals Incorporated (VRTX) vs Walmart Stores Inc (WMT) Price & Performance

Vertex Pharmaceuticals IncorporatedTrade
Walmart Stores IncTrade

Price performance (Past 24H)

Key statistics

Vertex Pharmaceuticals Incorporated vs Walmart Stores Inc — how do they compare? Vertex Pharmaceuticals Incorporated trades at $478.06 (market cap $121.95B), while Walmart Stores Inc trades at $109.92 (market cap $892.90B). The key difference: Walmart Stores Inc is far larger — about 7.3× Vertex Pharmaceuticals Incorporated's market cap, and Walmart Stores Inc pays a 0.88% dividend while Vertex Pharmaceuticals Incorporated pays none. Which is the better fit depends on your goals.

VRTXWMT
Market Cap
$121.95B$892.90B
Sector
HealthConsumer Staples
52-Week High
$529.59$134.20
52-Week Low
$366.54$95.67
Enterprise Value
$116.69B$956.35B
Volume
5,675,288
Dividend Yield
0.88%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Vertex Pharmaceuticals Incorporated

No Aura AI signal available yet.

Walmart Stores Inc

Walmart (WMT) trades at $114.24, down 0.62% today, with a neutral technical signal and strong fundamentals including consistent earnings beats and robust cash flow. Revenue reached $681.0B in 2025 (source: company filings, 2025), with net income margin improving to 3.13%. Recent news highlights AI innovation and delivery expansion, while analyst consensus remains bullish with a $142.10 price target.

The outlook is positive due to earnings momentum and strategic investments, but risks include competitive pressure from Amazon and margin volatility. Wall Street's strong buy rating (72.72% of analysts) supports upside potential, though investors should monitor execution against guidance.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Read more on VRTX

About Walmart Stores Inc

Walmart Inc. operates discount stores, supercenters, and neighborhood markets. The Company offers merchandise such as apparel, house wares, small appliances, electronics, musical instruments, books, home improvement, shoes, jewelry, toddler, games, household essentials, pets, pharmaceutical products, party supplies, and automotive tools. Walmart serves customers worldwide.

Read more on WMT